This is a routine, small-dollar insider intent-to-sell filing by a director. No material trading signal. Monitor for actual execution on Form 4, but the size is too small to warrant any position adjustment.
Price Chart
Executive Summary
Director Kimberly Manhard filed a Form 144 notice of intent to sell 500 shares of Inhibrx Biosciences common stock, with an estimated aggregate market value of approximately $55,888. The shares were acquired via open-market purchase on August 28, 2024, and the proposed sale is a small, routine transaction relative to the company's $1.6B market cap. The filing is a standard advance notice of intent to sell and carries minimal signal value for traders.
Key Facts
- Director Kimberly Manhard filed a Form 144 to sell 500 shares of INBX common stock.
- Estimated aggregate market value of the proposed sale is approximately $55,888.
- Shares were acquired via open-market purchase on August 28, 2024.
- The proposed sale represents a negligible fraction of the company's $1.6B market cap.
- The filing is an advance notice of intent to sell; the sale may not be executed.
Financial Impact
Proposed sale of 500 shares valued at approximately $55,888 — immaterial relative to $1.6B market cap.
Risk Factors
- The sale may still be executed, but the dollar amount is trivial.
- No other insider selling patterns are present to suggest broader concern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-006886 |
| Document: 0001959173-26-006886-index.html | 0001959173-26-006886 |
| Document: 0001959173-26-006886.txt | 0001959173-26-006886 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | Insider Buy | $90.50 | awaiting T+60 | — | $99.63 (+10.09%) |
Sep 28, 2026 28d ago | Insider Cluster | $104.83 | awaiting T+60 | — | $99.63 (−4.96%) |
Sep 17, 2026 5w ago | Insider Cluster | $109.35 | awaiting T+60 | — | $99.63 (−8.89%) |
Sep 15, 2026 5w ago | Insider Cluster | $101.77 | awaiting T+60 | — | $99.63 (−2.10%) |
Sep 15, 2026 5w ago | 144 | $101.77 | awaiting T+60 | — | $99.63 (−2.10%) |
Sep 14, 2026 6w ago | 144 | $105.61 | awaiting T+60 | — | $99.63 (−5.66%) |
Sep 11, 2026 6w ago | 144 | $109.27 | awaiting T+60 | — | $99.63 (−8.82%) |
Sep 10, 2026 6w ago | Insider Cluster | $109.27 | awaiting T+60 | — | $99.63 (−8.82%) |
Sep 8, 2026 6w ago | Insider Cluster | $112.86 | awaiting T+60 | — | $99.63 (−11.72%) |
Sep 8, 2026 6w ago | Insider Buy | $112.86 | awaiting T+60 | — | $99.63 (−11.72%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers